Mesoblast provides update on clinical programs of Prochymal
Filed with ASX · · 4 pages · English
Earlier from Mesoblast
- MSB & NIH Agree 120 Patient Trial In End-Stage Heart Failure
- MSB Accelerates Plans for Commercial Manufacturing Operation
- Mesoblast Receives $5.05m for Stem Cell Pipeline Development
- Circulation Publishes Improved Outcomes with Mesoblast Cells
- Key US Patent Granted For Treatment Of Rheumatoid Arthritis
Later from Mesoblast
- Half-Year Results & Strategic Update on Product Development
- Key MPC patents granted in United States and china
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast